Theranos was dissolved years ago, and its CEO, Elizabeth Holmes, is in prison, but the company’s patents based on bad science live on – a stark example of the persistence of faulty information.
Academic rigor, journalistic flair
Articles on Scientific fraud
Displaying all articles
A new screening tool to help study reviewers identify what’s fake or shoddy in research may be on the horizon. And everyday people can apply some of the same critical analysis tools.
How is a scientific article accepted for publication in an academic journal? What is the role of peer reviewers? Where does the system go astray?
Scientists need funding to do their work. But a new study finds turning to industry partners taints perceptions of university research, and including other kinds of partners doesn’t really help.
A century-old case of scientific fraud illustrates how hard it is to untangle the truth when access to new discoveries is limited.
Top contributors
-
Ellis N. Brandt Professor of Public Relations, Michigan State University
-
Professor of History, UMass Amherst
-
Directeur de recherche au CNRS, physicien, spécialiste d’optique, lasers et nanotechnologies, Université Sorbonne Paris Nord
-
Professor of Sociology, Michigan State University
-
Professor in Lyman Briggs College, Fisheries & Wildlife, and Philosophy, Michigan State University
-
PhD Student in Media and Information Studies, Michigan State University
-
Assistant Professor of the History of Science and Technology, Durham University
-
Chief Scientist, Center for Bioethics and Humanities and Professor of Medicine and Public Health, University of Colorado Anschutz Medical Campus
-
Associate Professor of Law, Fordham University
